Search for: "In Re: Red Hat, Inc. Securities Litigation" Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Sep 2013, 5:30 am by Barry Sookman
IMB+ Records Inc. 2013 ONSC 5382 http://t.co/8X5y5upZuQ -> Philip Pullman: illegal downloading is 'moral squalor' http://t.co/2aWCK5sNej -> Search engine indexing files fair use says court in Perfect 10, Inc. v. [read post]
29 Jan 2009, 1:46 pm
  From 2000 to 2007 Webbink served in various capacities with Red Hat, Inc., including General Counsel, Deputy General Counsel for Intellectual Property, Senior Vice President and Secretary. [read post]
23 Mar 2020, 1:48 pm by Kevin LaCroix
With respect to securities fraud class actions, a significant disconnect between the market’s understanding of a public company’s business plans and how that business is actually being managed is often the critical factor in anticipating stock price volatility and the potential for securities class actions. [read post]
14 Jul 2009, 6:37 am
(Editor’s Note: This post comes to us from Katrina Dewey, CEO & Publisher, Lawdragon, Inc.) [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]